LEADER 01658oam 2200349z- 450 001 9910136124703321 005 20151223084602.0 010 $a9780864928009 010 $a0864928009 035 $a(CKB)3710000000914895 035 $a(Perlego)964136 035 $a(EXLCZ)993710000000914895 100 $a20190509d2015 uy | 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aTwoism 210 $cicehouse poetry 311 08$a9780864928733 311 08$a0864928734 330 8 $aShortlisted, Dorothy Livesay Poetry Prize Part roving eye, part devotion, you wander hotel corridors, entering rooms not quite yours, trying on clothes, blankets, skins. Arguing with the body's limits and its trickery, you are always in disguise. Sometimes you're Leda; sometimes the swan. The rooms are haunted with gendered injuries of the past... but messengers arrive to guide you. In this stunning debut collection by Ali Blythe, every poem is unerringly built with hatches and escapes. Every line shimmers with life and shivers with fleeting materials. Someone or something is always leaving. The early poems, almost claustrophobic in their double vision, gradually give way to poems of aching beauty, erotically charged by the myth of completeness. Ultimately, whether you emerge or disappear, you are transformed. 606 $aPoetry 606 $aCanadian poetry 615 0$aPoetry. 615 0$aCanadian poetry. 676 $aC811/.6 700 $aBlythe$b Ali$f1976-$01247993 906 $aBOOK 912 $a9910136124703321 996 $aTwoism$92892799 997 $aUNINA LEADER 04917nam 2201369z- 450 001 9910580205403321 005 20220706 035 $a(CKB)5690000000012034 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87472 035 $a(oapen)doab87472 035 $a(EXLCZ)995690000000012034 100 $a20202207d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aImmunotherapy, Tumor Microenvironment and Survival Signaling 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (376 p.) 311 08$a3-0365-4419-4 311 08$a3-0365-4420-8 330 $aThe book is based on the Cancers journal Special Issue entitled "Immunotherapy, Tumor Microenvironment and Survival Signaling", and focuses on important problems concerning tumors and tumor microenvironment interactions, as well as novel immunotherapies such as CAR-T cell therapy. Immunotherapies have recently shown remarkable results in the treatment of cancer patients. However, there are still many questions that remain to be solved in regards to more effective therapies, such as the tumor heterogeneous profile, tumor microenvironment, and tumor survival epigenetic and genetic pathways, all of which make patients resistant to the presently available treatments for cancer. This book demonstrates different approaches to overcome the challenges faced by immunotherapies due to suppressive tumor microenvironments. This book includes 18 papers that can be divided into three chapters: 1. novel immunotherapies; 2. targeting tumor microenvironment and novel approaches; 3. targeting tumors and tumor microenvironment in different types of cancer. 606 $aClinical and internal medicine$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $aangiogenesis 610 $aantigen loss 610 $aAutophagy 610 $aBCMA 610 $abreast cancer 610 $acancer 610 $acancer immunotherapy 610 $acancer metabolism 610 $acancer nanomedicine 610 $acancer stem cells 610 $acancer vaccines 610 $aCAR macrophage 610 $aCAR T cell 610 $aCAR-T 610 $aCAR-T cells 610 $acardiotoxicity 610 $aCD11 610 $aCD18 610 $aCD19 610 $aCD37 610 $acell therapy 610 $acell-cell contact 610 $acheck point inhibitors 610 $acheckpoint 610 $achemotherapy 610 $achimeric antigen receptor 610 $achimeric antigen receptors 610 $aclonogenicity 610 $acolorectal cancer 610 $acombination therapy 610 $acrosstalk 610 $aDCLK1 610 $adendritic cells 610 $aelectroporation 610 $ahypoxia 610 $aimmune checkpoint inhibitor 610 $aimmune checkpoint inhibitors 610 $aimmune escape 610 $aimmunogenic cell death 610 $aimmunometabolism 610 $aimmunomodulation 610 $aimmunomodulators 610 $aimmunotherapeutic agent 610 $aimmunotherapies 610 $aimmunotherapy 610 $alentiviral transduction 610 $alentivirus 610 $aleukemia cells 610 $alung metastasis 610 $alymphoma 610 $alytic peptides 610 $amacrophages 610 $amelanoma 610 $amicroenvironment 610 $amiRNA 610 $amitochondria 610 $amitochondrial transfer 610 $amyeloid-derived suppressor cells 610 $an/a 610 $ananoparticles 610 $aoncolytic viral therapy 610 $apathogenesis 610 $apediatric solid tumors 610 $apersonalized medicine 610 $aprogrammed cell death 1 ligand 1 610 $aprogrammed cell death protein 1 610 $aregulatory T cells 610 $aresistance 610 $arisk factors 610 $asolid tumors 610 $atargeted therapy 610 $atargeted treatment 610 $atriple-negative breast cancer 610 $atuft cells 610 $atumor 610 $atumor antigen 610 $atumor antigens 610 $atumor immune evasion 610 $atumor microenvironment 610 $atumor stem cells 610 $atumor stroma 610 $atunneling nanotubes 610 $atyrosine kinase inhibitors 610 $a?2 integrins 615 7$aClinical and internal medicine 615 7$aMedicine and Nursing 700 $aGolubovskaya$b Vita$4edt$01304516 702 $aGolubovskaya$b Vita$4oth 906 $aBOOK 912 $a9910580205403321 996 $aImmunotherapy, Tumor Microenvironment and Survival Signaling$93027516 997 $aUNINA